JP2002520289A - 花椒の抽出物、これらを含有する薬剤製剤および化粧品製剤 - Google Patents
花椒の抽出物、これらを含有する薬剤製剤および化粧品製剤Info
- Publication number
- JP2002520289A JP2002520289A JP2000558829A JP2000558829A JP2002520289A JP 2002520289 A JP2002520289 A JP 2002520289A JP 2000558829 A JP2000558829 A JP 2000558829A JP 2000558829 A JP2000558829 A JP 2000558829A JP 2002520289 A JP2002520289 A JP 2002520289A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- pepper
- separator
- pharmaceutical
- bar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940116257 pepper extract Drugs 0.000 title claims abstract description 4
- 239000002537 cosmetic Substances 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title description 7
- 239000000284 extract Substances 0.000 claims description 40
- 238000000605 extraction Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- PCJWVQUPHYPGIE-UHFFFAOYSA-N n-butyl-4-methoxybenzamide Chemical compound CCCCNC(=O)C1=CC=C(OC)C=C1 PCJWVQUPHYPGIE-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 241000722363 Piper Species 0.000 description 10
- 235000002566 Capsicum Nutrition 0.000 description 8
- 239000006002 Pepper Substances 0.000 description 8
- 235000016761 Piper aduncum Nutrition 0.000 description 8
- 235000017804 Piper guineense Nutrition 0.000 description 8
- 235000008184 Piper nigrum Nutrition 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 5
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000003589 local anesthetic agent Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 229940055577 oleyl alcohol Drugs 0.000 description 4
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 4
- 230000003444 anaesthetic effect Effects 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 2
- 244000089698 Zanthoxylum simulans Species 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 2
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 2
- 229940047889 isobutyramide Drugs 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000107 myocyte Anatomy 0.000 description 2
- 210000000715 neuromuscular junction Anatomy 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- AAOFEMJZTYQZRH-UHFFFAOYSA-N 2-(1-butoxypropan-2-yloxy)ethanol Chemical compound CCCCOCC(C)OCCO AAOFEMJZTYQZRH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- -1 4-terpinol Chemical compound 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 102100032566 Carbonic anhydrase-related protein 10 Human genes 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000867836 Homo sapiens Carbonic anhydrase-related protein 10 Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 244000131415 Zanthoxylum piperitum Species 0.000 description 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 description 1
- 235000009932 Zanthoxylum simulans Nutrition 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- GMMUMXYUVFRBFV-UHFFFAOYSA-N dodecane;2-methyloxirane;oxirane Chemical compound C1CO1.CC1CO1.CCCCCCCCCCCC GMMUMXYUVFRBFV-UHFFFAOYSA-N 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940032067 peg-20 stearate Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 229940088640 ppg-25-laureth-25 Drugs 0.000 description 1
- 229940047663 ppg-26-buteth-26 Drugs 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000001991 scapula Anatomy 0.000 description 1
- 210000003497 sciatic nerve Anatomy 0.000 description 1
- 235000021264 seasoned food Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000008542 thermal sensitivity Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 230000018405 transmission of nerve impulse Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
酸化炭素で抽出することによって得られる新規の抽出物、およびこれを含有する
薬剤製剤ならびに化粧品製剤に関する。この抽出物は、抗炎症活性および鎮痛活
性を有し、掻痒の治療に使用することができる。
らに、中国およびインドの民間薬では、本植物のこの部位は、局所麻酔薬として
使用され、また赤痢の治療に使用される。エッセンシャルオイルは、1,8−シ
モール、リナロオール、4−テルピノール、カリオフィレン、リモネンなどの一
連のモノテルペンを含有するが、昆虫に対する強力な防虫剤として報告されてい
る。
た。
s(bungeanumの同意語)の根の樹皮から抽出されたケルクリスリンは
、血栓症の予防に活性があると開示された。JP01294657によれば、有
機溶媒で果皮を抽出することにより、舌に適用30秒後に既に局所麻酔効果を呈
し、20〜80分まで持続するイソブチルアミドを含有する抽出物が得られる。
れた花椒の果皮の抽出物は、溶媒によって得られる抽出物に特徴的な、局所麻酔
活性を呈することなく、顕著な鎮痛活性を有することが発見されている。本発明
生成物は、細かく粉砕または変形してペレットにした花椒の果皮を、圧力条件範
囲150から300バール、好ましくは180〜230バール下で、温度範囲3
5から55℃、好ましくは35〜40℃で、二酸化炭素で抽出して調製する。
族アルコール、脂肪族炭化水素などの混和しない溶媒、好ましくはn−ヘキサン
または石油エーテルで分配することにより、さらに精製して使用することもでき
る。
ることが判明し、したがって、薬剤分野および化粧品分野双方での使用に有用で
ある。
およびいかなる型の局所痛を緩和するのにも有用である。発明抽出物のさらに進
んだ適用は、掻痒の治療である。
げそりローションならびにクリーム、および局所鎮痛作用ならびに局所抗掻痒作
用が必要とされる、すべての皮膚治療において有用である。
(EDL)組織標本実験モデルを使用して、電気生理学的測定により評価した。
leyラットを使用した。長い坐骨神経と一緒にしたEDL筋を切断し、10分
毎に取り替えたリンゲル液の入った電気生理学用の容器中に設置した。試験抽出
物は、界面活性剤を加えるのが好ましいが、異なる濃度に分散させ、それにより
神経線維、神経筋接合部、および筋肉に接触するようになった。生理学的試験の
ために、3M KClで満たした細胞内微小電極を、自発的および神経の刺激に
より誘導された双方の電気的現象(筋細胞の微小終板電位、終板電位、膜電位)
を記録するために、筋細胞内に設置した。この目的のために、神経を刺激物質に
連結し、1秒に1回、任意に刺激した。筋細胞内の電気的事象を、信号増幅器に
連結された微小電極によって検出し、デジタルオシロスコープにより視覚化した
。
は、微小終板電位の頻度の増加、および自発的な終板電位の出現によって証明さ
れるように、神経筋接合部の伝達に、強力で一時的な活性化作用を及ぼす。反対
に、局所麻酔活性を有し、溶媒で得られる抽出物は、神経インパルスの伝達を減
少させ阻害する。
の熱感受性によって評価した。
治療した30分後に、被験者の肩甲骨領域に設置した。被験者が苦痛と感じる温
度値を測定した。実施例Iに従って調製した0.5%花椒抽出物を含有し、実施
例VIIに従って調製した乳剤0.5mlを投与した。試験抽出物の鎮痛活性を
、以下の報告結果に示す。
フォーミング剤、ゲル剤、その他の投与用には、軟カプセル剤、硬カプセル剤、
錠剤、または坐剤の形状に製剤化することができるが、発明抽出物は、皮膚治療
用には、クリーム剤またはフォーミング剤、全身性経路用には、軟カプセル剤、
咀嚼錠、または坐剤に製剤化するのが好ましい。
り5から100mgの間の範囲であるが、局所用の製剤中では、0.05から1
%へと幅がある。
のコンデンサとして2つの分離器を備える、超臨界気体用の25L抽出装置に抽
出した。
中に押出し、以下の実験条件下、臨界条件でCO2にて抽出した。
中は50バール。
縮する一方、植物性マトリックス中に存在する大部分の水を、第1分離器中で濃
縮した。抽出物を、第2分離器中で真空下、40℃を超えない温度で乾燥後、ペ
ースト状の抽出物1.5Kgを得たが、これはわずかに黄色であり、強烈に香り
、約25重量パーセントのイソブチルアミドを含有していた。HPLC分析を、
Hibar RT LiChrospher 100RP−18カラムで、表に
報告する溶出プロフィール(1mL/分)で行った。注入量は、濃度2mg/m
Lの溶液5μLとした。クロマトグラムを、図に報告する。
中に押出し、以下の実験条件下、臨界条件でCO2にて抽出した。
中は50バール。
縮する一方、植物性マトリックス中に存在する大部分の水を、第1分離器中で濃
縮した。抽出物を、第2分離器中で真空下、40℃を超えない温度で乾燥後、ペ
ースト状の抽出物1.5Kgを得たが、これはわずかに黄色/緑色であり、実施
例Iの抽出物と同様の化学的−物理的特性を有し、イソブチルアミドの含量が、
約20%であった。
中に押出し、以下の実験条件下、臨界条件でCO2にて抽出した。抽出器中の温
度40℃、圧力230バール。抽出されるべき薬剤の抽出に使用したCO2の割
合は、薬剤1Kgあたり27〜45Kgとした。抽出物を、分離器中で50バー
ル、20℃で濃縮した。真空下、40℃を超えない温度で乾燥後、ペースト状の
抽出物1.3Kgを得たが、これはわずかに黄色/緑色であり、実施例Iの抽出
物と同様の化学的−物理的特性を有していた。
メタノール水2.5Lに溶解し、n−ヘキサン各0.5Lで3回抽出した。ヘキ
サン相を、メタノール相に残留するべきイソブチルアミドをマーカーとして使用
して、メタノールで逆洗浄した。不活性ヘキサン相を除去した一方、メタノール
相を合し、水0.6Lで希釈し、n−ヘキサン0.6Lで2回、再抽出した。合
わせたヘキサン相を、0.3%木炭で脱色し、Na2SO4上で乾燥し、40℃を
超えない温度で真空下に油状物へと濃縮して、はちみつ様の稠度を有し、イソブ
チルアミドを約50%含有する油性抽出物0.22Kgを得た。
Claims (5)
- 【請求項1】 果皮を超臨界のCO2で抽出することにより得られる、花椒
の抽出物。 - 【請求項2】 温度範囲35から55℃、圧力範囲150から300バール
下で、CO2で抽出することにより得られる、請求項1に記載の抽出物。 - 【請求項3】 イソブチルアミド含量を、20重量%から50重量%の範囲
で含有する、請求項1および2に記載の抽出物。 - 【請求項4】 請求項1から3に記載の抽出物を、適切な賦形剤と混合して
、活性成分として含有する薬剤組成物。 - 【請求項5】 請求項1から3に記載の抽出物を適切な賦形剤と混合して、
活性成分として含有する化粧品組成物。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT98MI001542A ITMI981542A1 (it) | 1998-07-07 | 1998-07-07 | Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche |
IT98A001542 | 1998-07-07 | ||
ITMI98A001542 | 1998-07-07 | ||
PCT/EP1999/002358 WO2000002570A1 (en) | 1998-07-07 | 1999-04-07 | Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002520289A true JP2002520289A (ja) | 2002-07-09 |
JP4776776B2 JP4776776B2 (ja) | 2011-09-21 |
Family
ID=11380385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000558829A Expired - Lifetime JP4776776B2 (ja) | 1998-07-07 | 1999-04-07 | 花椒の抽出物、これらを含有する薬剤製剤および化粧品製剤 |
Country Status (21)
Country | Link |
---|---|
US (1) | US6419950B2 (ja) |
EP (1) | EP1096944B1 (ja) |
JP (1) | JP4776776B2 (ja) |
KR (1) | KR100620148B1 (ja) |
CN (1) | CN1308541A (ja) |
AT (1) | ATE213949T1 (ja) |
AU (1) | AU749947B2 (ja) |
CA (1) | CA2336542C (ja) |
CZ (1) | CZ292523B6 (ja) |
DE (1) | DE69900999T2 (ja) |
DK (1) | DK1096944T3 (ja) |
ES (1) | ES2173732T3 (ja) |
HU (1) | HU228795B1 (ja) |
IL (2) | IL140702A0 (ja) |
IT (1) | ITMI981542A1 (ja) |
NO (1) | NO325091B1 (ja) |
PL (1) | PL191160B1 (ja) |
PT (1) | PT1096944E (ja) |
RU (1) | RU2214817C2 (ja) |
SK (1) | SK284804B6 (ja) |
WO (1) | WO2000002570A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013103901A (ja) * | 2011-11-14 | 2013-05-30 | T Hasegawa Co Ltd | ヒドロキシサンショオール含有物の製造方法 |
WO2020040315A1 (ja) * | 2018-08-23 | 2020-02-27 | 山本 芳栄 | サンショオール類の安定化方法 |
JP7433125B2 (ja) | 2020-04-17 | 2024-02-19 | オリザ油化株式会社 | 口腔用抗菌剤 |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2807317B1 (fr) * | 2000-04-10 | 2002-08-16 | Indena Sa | Compositions de soin capillaire |
KR100462788B1 (ko) * | 2001-11-06 | 2004-12-20 | 김성진 | 천초 추출물을 함유하는 뇌세포 보호 및 기억력 증진용조성물 |
JP2003321315A (ja) * | 2002-04-24 | 2003-11-11 | Hiromi Nishii | 植物エキス配合液剤 |
US20040013723A1 (en) * | 2002-07-16 | 2004-01-22 | PARIKH Rita M. | Oral care capsules |
JP2006096666A (ja) * | 2002-10-31 | 2006-04-13 | Kaneka Corp | 選択的ヒトβ3アドレナリン受容体アゴニスト剤 |
ITMI20032286A1 (it) * | 2003-11-24 | 2005-05-25 | Indena Spa | Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne |
US7087497B2 (en) * | 2004-03-04 | 2006-08-08 | Applied Materials | Low-thermal-budget gapfill process |
ITMI20042414A1 (it) | 2004-12-17 | 2005-03-17 | Indena Spa | Formulazione per il trattamento di affezioni delle prime vie respiratorie |
EP1882473A1 (en) | 2006-07-28 | 2008-01-30 | Indena S.P.A. | Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs |
FR2905854B1 (fr) * | 2006-09-15 | 2010-07-30 | Fabre Pierre Dermo Cosmetique | Composition a base de xanthoxyline et son utilisation en cosmetique |
ITMI20071136A1 (it) | 2007-06-04 | 2008-12-05 | Velleja Res Srl | Formulazioni topiche per la prevenzione e il trattamento degli stati infiammatori e/o infettivi dell'aera genitale |
ITMI20080395A1 (it) * | 2008-03-10 | 2009-09-11 | Indena Spa | Formulazioni per il trattamento delle verruche e delle placche psoriatiche |
ITMI20090247A1 (it) * | 2009-02-23 | 2010-08-24 | Indena Spa | Metodo di trattamento cosmetico delle rughe basato su un estratto di zanthoxylum bungeanum |
CN102077971A (zh) * | 2009-11-26 | 2011-06-01 | 天津市春升清真食品有限公司 | 一种熟香花椒精油 |
RU2012148696A (ru) | 2010-05-18 | 2014-06-27 | Индена С.П.А. | Композиции для лечения гинекологических заболеваний |
CN102058709A (zh) * | 2011-01-20 | 2011-05-18 | 黑龙江省中医研究院 | 一种具有抗解脲支原体和人型支原体感染作用的花椒提取物 |
US20140120190A1 (en) * | 2012-10-20 | 2014-05-01 | Dong-Qing WEI | Methods of preparing prickly-ash peel extracts and cosmetic compositions incorporating prickly-ash peel extracts |
ITMI20130807A1 (it) * | 2013-05-16 | 2014-11-17 | Indena Spa | Combinazioni di estratti di serenoa repens e di estratti lipofili di zingiber officinalis e di echinacea angustifolia, loro uso e formulazioni che li contengono |
DE102013213596A1 (de) | 2013-07-11 | 2015-01-15 | Henkel Ag & Co. Kgaa | Mund- und Zahnpflege- und -reinigungsmittel zur Zahnfleischvitalisierung |
ITLE20130014A1 (it) * | 2013-09-26 | 2015-03-27 | Ekuberg Pharma Srl | Composizione per crema lenitiva |
KR102350519B1 (ko) * | 2014-02-20 | 2022-01-14 | 인데나 에스.피.에이 | 말초성 염증 및 통증을 감소시키는데 유용한 울금 및 에키네시아 안구스티폴리아의 추출물을 함유하는 조성물 |
CN104784317B (zh) * | 2015-05-08 | 2017-10-31 | 李会杰 | 椒目中植物化学素的分离方法 |
ES2610208B1 (es) * | 2015-10-22 | 2018-02-07 | Innovativehealth Group, S.L. | Formulación cosmética de uso tópico para el cuidado de la piel atópica |
ITUB20156036A1 (it) | 2015-11-30 | 2017-05-30 | Indena Spa | Estratti di echinacea angustifolia e zanthoxylum bungeanum per la prevenzione e/o il trattamento dell?obesita e del sovrappeso |
ITUB20161030A1 (it) * | 2016-02-24 | 2017-08-24 | Indena Spa | Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore |
ITUA20164757A1 (it) | 2016-06-29 | 2017-12-29 | Indena Spa | Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore osteoarticolare e del danno cartilagineo |
EP3335716A1 (en) * | 2016-12-15 | 2018-06-20 | Indena S.p.A. | Process for the preparation of powder compositions |
CN107141231B (zh) * | 2017-04-11 | 2019-08-27 | 双柏一禾农业科技有限公司 | 高纯度花椒麻素的制备方法 |
CN109718297A (zh) * | 2018-08-06 | 2019-05-07 | 四川省中医药科学院 | 一种花椒提取物和辣椒碱的药物组合物 |
CN112293500B (zh) * | 2019-07-26 | 2023-03-31 | 成都大学 | 一种花椒籽油干粉的制备方法 |
CN111568794B (zh) * | 2020-06-17 | 2021-05-18 | 上海交通大学 | 花椒提取物中活性成分wgx50的新用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09255583A (ja) * | 1996-03-25 | 1997-09-30 | Yamamoto Koryo Kk | 抗かゆみ剤 |
JPH10114643A (ja) * | 1996-10-11 | 1998-05-06 | L'oreal Sa | 高電解質含量を有する水中油型エマルションおよび、特に、刺激および/または感受性皮膚現象を治療するための皮膚化粧品におけるその用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0283257B1 (en) * | 1987-03-20 | 1993-01-13 | Sumitomo Seika Chemicals Co., Ltd. | Edible composition |
JPH01294657A (ja) * | 1987-12-24 | 1989-11-28 | Wakunaga Pharmaceut Co Ltd | 新規アミド化合物及びその製造法 |
-
1998
- 1998-07-07 IT IT98MI001542A patent/ITMI981542A1/it unknown
-
1999
- 1999-04-07 WO PCT/EP1999/002358 patent/WO2000002570A1/en active IP Right Grant
- 1999-04-07 CN CN99808222A patent/CN1308541A/zh active Pending
- 1999-04-07 IL IL14070299A patent/IL140702A0/xx active IP Right Grant
- 1999-04-07 SK SK7-2001A patent/SK284804B6/sk not_active IP Right Cessation
- 1999-04-07 AT AT99915744T patent/ATE213949T1/de active
- 1999-04-07 ES ES99915744T patent/ES2173732T3/es not_active Expired - Lifetime
- 1999-04-07 JP JP2000558829A patent/JP4776776B2/ja not_active Expired - Lifetime
- 1999-04-07 KR KR1020017000047A patent/KR100620148B1/ko not_active IP Right Cessation
- 1999-04-07 HU HU0104923A patent/HU228795B1/hu unknown
- 1999-04-07 DE DE69900999T patent/DE69900999T2/de not_active Expired - Lifetime
- 1999-04-07 EP EP99915744A patent/EP1096944B1/en not_active Expired - Lifetime
- 1999-04-07 AU AU34206/99A patent/AU749947B2/en not_active Expired
- 1999-04-07 CZ CZ200121A patent/CZ292523B6/cs not_active IP Right Cessation
- 1999-04-07 RU RU2001101448/14A patent/RU2214817C2/ru active
- 1999-04-07 CA CA2336542A patent/CA2336542C/en not_active Expired - Lifetime
- 1999-04-07 PL PL345262A patent/PL191160B1/pl unknown
- 1999-04-07 DK DK99915744T patent/DK1096944T3/da active
- 1999-04-07 PT PT99915744T patent/PT1096944E/pt unknown
-
2000
- 2000-12-28 US US09/749,448 patent/US6419950B2/en not_active Expired - Lifetime
-
2001
- 2001-01-02 IL IL140702A patent/IL140702A/en not_active IP Right Cessation
- 2001-01-03 NO NO20010033A patent/NO325091B1/no not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09255583A (ja) * | 1996-03-25 | 1997-09-30 | Yamamoto Koryo Kk | 抗かゆみ剤 |
JPH10114643A (ja) * | 1996-10-11 | 1998-05-06 | L'oreal Sa | 高電解質含量を有する水中油型エマルションおよび、特に、刺激および/または感受性皮膚現象を治療するための皮膚化粧品におけるその用途 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013103901A (ja) * | 2011-11-14 | 2013-05-30 | T Hasegawa Co Ltd | ヒドロキシサンショオール含有物の製造方法 |
WO2020040315A1 (ja) * | 2018-08-23 | 2020-02-27 | 山本 芳栄 | サンショオール類の安定化方法 |
JP2020029422A (ja) * | 2018-08-23 | 2020-02-27 | 山本 芳栄 | サンショオール類の安定化方法 |
JP7433125B2 (ja) | 2020-04-17 | 2024-02-19 | オリザ油化株式会社 | 口腔用抗菌剤 |
Also Published As
Publication number | Publication date |
---|---|
US6419950B2 (en) | 2002-07-16 |
KR20010053374A (ko) | 2001-06-25 |
HUP0104923A2 (hu) | 2002-05-29 |
PL345262A1 (en) | 2001-12-03 |
AU749947B2 (en) | 2002-07-04 |
CA2336542C (en) | 2010-10-12 |
KR100620148B1 (ko) | 2006-09-05 |
HUP0104923A3 (en) | 2002-07-29 |
HU228795B1 (en) | 2013-05-28 |
ITMI981542A1 (it) | 2000-01-07 |
RU2214817C2 (ru) | 2003-10-27 |
DE69900999T2 (de) | 2003-02-06 |
CZ200121A3 (cs) | 2001-07-11 |
PT1096944E (pt) | 2002-07-31 |
CZ292523B6 (cs) | 2003-10-15 |
DK1096944T3 (da) | 2002-06-17 |
EP1096944A1 (en) | 2001-05-09 |
IL140702A0 (en) | 2002-02-10 |
SK72001A3 (en) | 2001-09-11 |
US20010002260A1 (en) | 2001-05-31 |
JP4776776B2 (ja) | 2011-09-21 |
SK284804B6 (sk) | 2005-11-03 |
ES2173732T3 (es) | 2002-10-16 |
PL191160B1 (pl) | 2006-03-31 |
EP1096944B1 (en) | 2002-03-06 |
NO325091B1 (no) | 2008-01-28 |
WO2000002570A1 (en) | 2000-01-20 |
CA2336542A1 (en) | 2000-01-20 |
AU3420699A (en) | 2000-02-01 |
DE69900999D1 (de) | 2002-04-11 |
NO20010033D0 (no) | 2001-01-03 |
CN1308541A (zh) | 2001-08-15 |
IL140702A (en) | 2006-10-31 |
ATE213949T1 (de) | 2002-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002520289A (ja) | 花椒の抽出物、これらを含有する薬剤製剤および化粧品製剤 | |
US5476651A (en) | Cosmetic or pharmaceutical composition, especially dermatological composition, intended for promoting the pigmentation of the skin or hair, containing an extract of cyperus, and the process for its manufacture | |
JP2969274B2 (ja) | 肌荒れ防止改善剤 | |
US7229650B2 (en) | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) | |
KR102140652B1 (ko) | 비타민 c를 포함하는 조성물 | |
JP2001500131A (ja) | 脂質障壁合成を強化するための局所組成物および方法 | |
JP2001288066A (ja) | 皮膚バリアー機能改善剤 | |
US20030044476A1 (en) | Use of a flavonoid extract of ginkgo biloba substantially devoid of terpenes, in the dentibuccal field, and composition containing such extract | |
JP3091962B2 (ja) | テストステロン−5α−レダクターゼ阻害剤 | |
KR100482694B1 (ko) | 발모 촉진용 리포좀 베이스, 그를 포함한 발모 촉진용화장료 조성물 및 그를 이용한 생약 성분의 흡수율 향상방법 | |
US20050175576A1 (en) | Hair growth inhibitors and composition containing same | |
EP1352637A1 (en) | Hair growth inhibitors and compositions containing the same | |
JP4197194B2 (ja) | 細胞間接着抑制用経口投与剤 | |
JPH1192332A (ja) | 皮膚外用剤組成物 | |
JP3154712B2 (ja) | ネオリグナン誘導体と燐脂質との複合体、その使用法及び該複合体を含む製薬学的及び化粧品的製剤 | |
KR20200058730A (ko) | 탈모방지 또는 발모촉진용 조성물 | |
KR102602321B1 (ko) | 검정콩, 풋귤 및 울금 추출물을 포함하는 탈모 증상 예방 또는 개선용 화장료 조성물 | |
KR102179114B1 (ko) | 장구밥 나무 추출물을 유효성분으로 포함하는 보습용 또는 피부 장벽 기능 개선용 조성물 | |
JP3536872B2 (ja) | 育毛剤 | |
FR2876909A1 (fr) | Composition a base d'huile de chaulmoogra et de bases xanthiques pour le traitement des surchages adipeuses. | |
KR101200565B1 (ko) | 국소 적용을 위한 더덕 추출물 함유 조성물 | |
KR20230141034A (ko) | 검정콩, 풋귤 및 울금 추출물의 혼합물을 함유한 리포좀을 포함하는 탈모 예방 또는 개선용 화장료 조성물 | |
KR20230072619A (ko) | 울금 당화발효물을 포함하는 화장료 조성물 | |
EP2554179B1 (en) | Composition based on a vegetable extract for the treatment of cutaneous inflammatory forms, in particular psoriasis. | |
KR20150050984A (ko) | 알칼로이드를 유효성분으로 포함하는 항염 화장료 조성물 또는 항염 피부 외용제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060406 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20060406 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091021 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100118 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100125 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100526 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100826 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110104 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110120 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110601 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110629 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140708 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |